Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Diabetes Reviews
  4. Fast Track Articles
  5. Fast Track Article
image of Trends in Total Antioxidant Status and Other Biochemical Parameters in Type 2 Diabetes Mellitus: A Case-control Study
file format pdf download PDF

Abstract

Objectives

Owing to the existing evidence of the implication of oxidative stress in the pathophysiology of type 2 diabetes mellitus (T2DM), the present study aims to investigate the correlation of serum total antioxidant status (TAS) with comorbidities, various biochemical parameters, and duration of T2DM. Various factors contributing to disease prevalence and trends in other biochemical parameters are assessed.

Methods

A retrospective observational study of 246 patients with T2DM whose data were retrieved from the Proficiency Health Diagnostic Lab System in Al Ain. Data were analyzed using the Statistical Package for the Social Sciences (SPSS) program.

Results

The prevalence of T2DM was found to be higher in gender (male), age (≥45 years), ethnicity (Middle Eastern), BMI (≥25), family history, and metabolic syndrome (hypertension and dyslipidemia). TAS was found to be significantly higher in patients with comorbidities, than in those without, particularly dyslipidemia and micro-albuminuria (<0.05). TAS was weakly positively correlated with various T2DM biochemical parameters (<0.05), except for Fasting blood glucose (FBG) (=0.061). TAS was weakly negatively correlated with BMI (≥25) (=0.042). Albumin-to-creatinine ratio (ACR) was statistically higher in hypertensives than normotensives (=0.049). Duration of disease was only significantly correlated with ACR (=0.325, =0.001). Uric acid levels were statistically higher in patients with microalbuminuria than in patients without microalbuminuria (=0.001).

Conclusion

TAS was higher in patients with dyslipidemia and microalbuminuria, suggesting the influence of other factors such as uric acid and lipid-lowering agents. TAS could be an important factor in the management of T2DM cases. This needs to be further investigated in future studies to fill the gap found in the literature.

© 2025 The Author(s). Published by Bentham Science Publishers
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Loading

Article metrics loading...

/content/journals/cdr/10.2174/0115733998336940241219182916
2025-01-09
2025-07-12

  • From This Site

    /content/journals/cdr/10.2174/0115733998336940241219182916
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
The full text of this item is not currently available.

References

  1. Gupta S. Sharma N. Arora S. Verma S. Diabetes: A review of its pathophysiology, and advanced methods of mitigation. Curr. Med. Res. Opin. 2024 40 5 773 780 10.1080/03007995.2024.2333440 38512073
    [Google Scholar]
  2. Zhou B. Lu Y. Hajifathalian K. Bentham J. Cesare D.M. Danaei G. Bixby H. Cowan M.J. Ali M.K. Taddei C. Lo W.C. Santos R.B. Stevens G.A. Riley L.M. Miranda J.J. Bjerregaard P. Rivera J.A. Fouad H.M. Ma G. Mbanya J.C. McGarvey S.T. Mohan V. Onat A. Pilav A. Ramachandran A. Romdhane H.B. Paciorek C.J. Bennett J.E. Ezzati M. Abdeen Z.A. Kadir A.K. Rmeileh A.N.M. Cazares A.B. Adams R. Aekplakorn W. Salinas A.C.A. Agyemang C. Ahmadvand A. Othman Al.A.R. Alkerwi A. Amouyel P. Amuzu A. Andersen L.B. Anderssen S.A. Anjana R.M. Skhiri A.H. Aris T. Arlappa N. Arveiler D. Assah F.K. Avdicová M. Azizi F. Balakrishna N. Bandosz P. Barbagallo C.M. Barceló A. Batieha A.M. Baur L.A. Romdhane H.B. Benet M. Ortiz B.A. Bharadwaj S. Bhargava S.K. Bi Y. Bjerregaard P. Bjertness E. Bjertness M.B. Björkelund C. Blokstra A. Bo S. Boehm B.O. Boissonnet C.P. Bovet P. Brajkovich I. Breckenkamp J. Brenner H. Brewster L.M. Brian G.R. Bruno G. Bugge A. Cabrera de León A. Can G. Cândido A.P. Capuano V. Carlsson A.C. Carvalho M.J. Casanueva F.F. Casas J.P. Caserta C.A. Castetbon K. Chamukuttan S. Chaturvedi N. Chen C.J. Chen F. Chen S. Cheng C.Y. Chetrit A. Chiou S.T. Cho Y. Chudek J. Cifkova R. Claessens F. Concin H. Cooper C. Cooper R. Costanzo S. Cottel D. Cowell C. Crujeiras A.B. D’Arrigo G. Dallongeville J. Dankner R. Dauchet L. Gaetano d.G. Henauw D.S. Deepa M. Dehghan A. Deschamps V. Dhana K. Castelnuovo D.A.F. Djalalinia S. Doua K. Drygas W. Du Y. Dzerve V. Egbagbe E.E. Eggertsen R. Ati E.J. Elosua R. Erasmus R.T. Erem C. Ergor G. Eriksen L. Escobedo-de la Peña J. Fall C.H. Farzadfar F. Redondo F.F.J. Ferguson T.S. Bergés F.D. Ferrari M. Ferreccio C. Feskens E.J. Finn J.D. Föger B. Foo L.H. Forslund A.S. Fouad H.M. Francis D.K. Mdo F.C. Franco O.H. Frontera G. Furusawa T. Gaciong Z. Garnett S.P. Gaspoz J.M. Gasull M. Gates L. Geleijnse J.M. Ghasemian A. Ghimire A. Giampaoli S. Gianfagna F. Giovannelli J. Giwercman A. Gross M.G. Rivas G.J.P. Gorbea M.B. Gottrand F. Grafnetter D. Grodzicki T. Grøntved A. Gruden G. Gu D. Guan O.P. Guerrero R. Guessous I. Guimaraes A.L. Gutierrez L. Hambleton I.R. Hardy R. Kumar H.R. Hata J. He J. Heidemann C. Herrala S. Hihtaniemi I.T. Ho S.Y. Ho S.C. Hofman A. Hormiga C.M. Horta B.L. Houti L. Howitt C. Htay T.T. Htet A.S. Htike M.M. Hu Y. Hussieni A.S. Huybrechts I. Hwalla N. Iacoviello L. Iannone A.G. Ibrahim M.M. Ikeda N. Ikram M.A. Irazola V.E. Islam M. Iwasaki M. Jacobs J.M. Jafar T. Jamil K.M. Jasienska G. Jiang C.Q. Jonas J.B. Joshi P. Kafatos A. Leibovici K.O. Kasaeian A. Katz J. Kaur P. Kavousi M. Kiukaanniemi K.S. Kelishadi R. Kengne A.P. Kersting M. Khader Y.S. Khalili D. Khang Y.H. Kiechl S. Kim J. Kolsteren P. Korrovits P. Kratzer W. Kromhout D. Kujala U.M. Kula K. Kyobutungi C. Laatikainen T. Lachat C. Laid Y. Lam T.H. Landrove O. Lanska V. Lappas G. Laxmaiah A. Leclercq C. Lee J. Lee J. Lehtimäki T. Lekhraj R. Muñoz L.L.M. Li Y. Lim W.Y. Costa L.M.F. Lin H.H. Lin X. Lissner L. Lorbeer R. Lozano J.E. Luksiene D. Lundqvist A. Lytsy P. Ma G. Coelho M.G.L. Machi S. Maggi S. Magliano D.J. Makdisse M. Rao M.K. Manios Y. Manzato E. Margozzini P. Vidal M.P. Martorell R. Masoodi S.R. Mathiesen E.B. Matsha T.E. Mbanya J.C. McFarlane S.R. McGarvey S.T. McLachlan S. McNulty B.A. Benchekor M.S. Meirhaeghe A. Menezes A.M. Merat S. Meshram I.I. Mi J. Miquel J.F. Miranda J.J. Mohamed M.K. Mohammad K. Mohammadifard N. Mohan V. Yusoff M.M.F. Møller N.C. Molnár D. Mondo C.K. Morejon A. Moreno L.A. Morgan K. Moschonis G. Mossakowska M. Mostafa A. Mota J. Motta J. Mu T.T. Muiesan M.L. Nurasyid M.M. Mursu J. Nagel G. Námešná J. Nang E.E. NangThetia V.B. Muñoz N.E.M. Ndiaye N.C. Nenko I. Nervi F. Nguyen N.D. Nguyen Q.N. Martínez N.R.E. Ning G. Ninomiya T. Noale M. Noto D. Nsour M.A. Avilés O.A.M. Oh K. Onat A. Ordunez P. Osmond C. Otero J.A. Dabo O.E. Pahomova E. Palmieri L. Jonas P.S. Panza F. Parsaeian M. Peixoto S.V. Pelletier C. Peltonen M. Peters A. Peykari N. Pham S.T. Pilav A. Pitakaka F. Piwonska A. Piwonski J. Rubió P.P. Porta M. Portegies M.L. Poustchi H. Pradeepa R. Price J.F. Punab M. Qasrawi R.F. Qorbani M. Radisauskas R. Rahman M. Raitakari O. Rao S.R. Ramachandran A. Ramke J. Ramos R. Rampal S. Rathmann W. Redon J. Reganit P.F. Rigo F. Robinson S.M. Robitaille C. Artalejo R.F. Rodriguez-Perez Mdel C. Villamizar R.L.A. Martinez R.R. Ronkainen K. Rosengren A. Rubinstein A. Rui O. Betancourt R.B.S. Horimoto R.R.V. Rutkowski M. Sabanayagam C. Sachdev H.S. Saidi O. Sakarya S. Salanave B. Salonen J.T. Salvetti M. Abanto S.J. Santos D. Santos d.R.N. Santos R. Saramies J.L. Sardinha L.B. Sarrafzadegan N. Saum K.U. Scazufca M. Schargrodsky H. Nave S.C. Sein A.A. Sharma S.K. Shaw J.E. Shibuya K. Shin Y. Shiri R. Siantar R. Sibai A.M. Simon M. Simons J. Simons L.A. Sjostrom M. Hilczer S.J. Slusarczyk P. Smeeth L. Snijder M.B. So H.K. Sobngwi E. Söderberg S. Solfrizzi V. Sonestedt E. Soumare A. Staessen J.A. Stathopoulou M.G. Johannessen S.J. Stehle P. Stein A.D. Stessman J. Stöckl D. Stokwiszewski J. Stronks K. Strufaldi M.W. Sun C.A. Sundström J. Sung Y.T. Suriyawongpaisal P. Sy R.G. Tai E.S. Tamosiunas A. Tang L. Tarawneh M. Mamani T.C.B. Taylor A. Theobald H. Thijs L. Thuesen B.H. Tolonen H.K. Tolstrup J.S. Topbas M. Torrent M. Traissac P. Trinh O.T. Reid T.M.K. Tuomainen T.P. Turley M.L. Tzourio C. Ueda P. Ukoli F.A. Ulmer H. Uusitalo H.M. Valdivia G. Valvi D. Rossem v.L. Valkengoed v.I.G. Vanderschueren D. Vanuzzo D. Vega T. Melendez V.G. Veronesi G. Verschuren W.M. Verstraeten R. Viet L. Vioque J. Virtanen J.K. Siest V.S. Viswanathan B. Vollenweider P. Voutilainen S. Vrijheid M. Wade A.N. Wagner A. Walton J. Mohamud W.W.N. Wang F. Wang M.D. Wang Q. Wang Y.X. Wannamethee S.G. Weerasekera D. Whincup P.H. Widhalm K. Wiecek A. Wijga A.H. Wilks R.J. Willeit J. Wilsgaard T. Wojtyniak B. Wong T.Y. Woo J. Woodward M. Wu F.C. Wu S.L. Xu H. Yan W. Yang X. Ye X. Yoshihara A. Coleman Y.N.O. Zambon S. Zargar A.H. Zdrojewski T. Zhao W. Zheng Y. Cisneros J.J. Worldwide trends in diabetes since 1980: A pooled analysis of 751 population-based studies with 4·4 million participants. Lancet 2016 387 10027 1513 1530 10.1016/S0140‑6736(16)00618‑8 27061677
    [Google Scholar]
  3. IDF Diabetes Atlas. 9th Ed. Bagsværd, Denmark International Diabetes Federation 2019
    [Google Scholar]
  4. Rahimlou M. Mirzaei K. Keshavarz S.A. nezhad H.A. Association of circulating adipokines with metabolic dyslipidemia in obese versus non-obese individuals. Diabetes Metab. Syndr. 2016 10 1 Suppl. 1 S60 S65 10.1016/j.dsx.2015.09.015 26482964
    [Google Scholar]
  5. Bakhtiary M. Morvaridzadeh M. Agah S. Rahimlou M. Christopher E. Zadro J.R. Heshmati J. Effect of probiotic, prebiotic, and synbiotic supplementation on cardiometabolic and oxidative stress parameters in patients with chronic kidney disease: A systematic review and meta-analysis. Clin. Ther. 2021 43 3 e71 e96 10.1016/j.clinthera.2020.12.021 33526314
    [Google Scholar]
  6. Zhang Z.Y. Miao L.F. Qian L.L. Wang N. Qi M.M. Zhang Y.M. Dang S.P. Wu Y. Wang R.X. Molecular mechanisms of glucose fluctuations on diabetic complications. Front. Endocrinol. 2019 10 640 10.3389/fendo.2019.00640 31620092
    [Google Scholar]
  7. Shields H.J. Traa A. Raamsdonk V.J.M. Beneficial and detrimental effects of reactive oxygen species on lifespan: A comprehensive review of comparative and experimental studies. Front. Cell Dev. Biol. 2021 9 628157 10.3389/fcell.2021.628157 33644065
    [Google Scholar]
  8. Halim M. Halim A. The effects of inflammation, aging and oxidative stress on the pathogenesis of diabetes mellitus (type 2 diabetes). Diabetes Metab. Syndr. 2019 13 2 1165 1172 10.1016/j.dsx.2019.01.040 31336460
    [Google Scholar]
  9. Sharma A. Mittal S. Aggarwal R. Chauhan M.K. Diabetes and cardiovascular disease: Inter-relation of risk factors and treatment. Future J. Pharm. Sci. 2020 6 1 130 10.1186/s43094‑020‑00151‑w
    [Google Scholar]
  10. Alkadi H. A review on free radicals and antioxidants. Infect. Disord. Drug Targets 2020 20 1 16 26 10.2174/22123989OTEznMzIwTcVY 29952268
    [Google Scholar]
  11. Zheng Y. Ley S.H. Hu F.B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat. Rev. Endocrinol. 2018 14 2 88 98 10.1038/nrendo.2017.151 29219149
    [Google Scholar]
  12. Kuchelmeister F van de Geer S Finite sample rates for logistic regression with small noise or few samples. arXiv:2305.15991 2024 1 6 10.1007/s13171‑024‑00358‑6
    [Google Scholar]
  13. Rodgers J.L. Jones J. Bolleddu S.I. Vanthenapalli S. Rodgers L.E. Shah K. Karia K. Panguluri S.K. Cardiovascular risks associated with gender and aging. J. Cardiovasc. Dev. Dis. 2019 6 2 19 10.3390/jcdd6020019 31035613
    [Google Scholar]
  14. Tramunt B. Smati S. Grandgeorge N. Lenfant F. Arnal J.F. Montagner A. Gourdy P. Sex differences in metabolic regulation and diabetes susceptibility. Diabetologia 2020 63 3 453 461 10.1007/s00125‑019‑05040‑3 31754750
    [Google Scholar]
  15. Awadi A.F. Hassanein M. Hussain H.Y. Prevalence of diabetes and associated health risk factors among adults in dubai, united arab emirates: Results from dubai household survey 2019. DOAJ 2021 26 4 164 173
    [Google Scholar]
  16. Sulaiman N. Mahmoud I. Hussein A. Elbadawi S. Abusnana S. Zimmet P. Shaw J. Diabetes risk score in the united arab emirates: A screening tool for the early detection of type 2 diabetes mellitus. BMJ Open Diabetes Res. Care 2018 6 1 e000489 10.1136/bmjdrc‑2017‑000489 29629178
    [Google Scholar]
  17. Nordström A. Hadrévi J. Olsson T. Franks P.W. Nordström P. Higher prevalence of type 2 diabetes in men than in women is associated with differences in visceral fat mass. J. Clin. Endocrinol. Metab. 2016 101 10 3740 3746 10.1210/jc.2016‑1915 27490920
    [Google Scholar]
  18. Aamir A.H. Haq U.Z. Mahar S.A. Qureshi F.M. Ahmad I. Jawa A. Sheikh A. Raza A. Fazid S. Jadoon Z. Ishtiaq O. Safdar N. Afridi H. Heald A.H. Diabetes prevalence survey of pakistan (dps-pak): Prevalence of type 2 diabetes mellitus and prediabetes using hba1c: A population-based survey from pakistan. BMJ Open 2019 9 2 e025300 10.1136/bmjopen‑2018‑025300 30796126
    [Google Scholar]
  19. Gatineau M. Hancock C. Holman N. Adult obesity and type 2 diabetes. Public Health England 2014 5 14
    [Google Scholar]
  20. Center, Dubai Statistics. Number of population estimated by nationality-emirate of dubai. 2017 Available from: https://www.dsc.gov.ae/Report/DSC_SYB_2017_01%20_%2003.pdf
  21. Hamoudi R. Saheb Sharif-Askari N. Saheb Sharif-Askari F. Abusnana S. Aljaibeji H. Taneera J. Sulaiman N. Prediabetes and diabetes prevalence and risk factors comparison between ethnic groups in the United Arab Emirates. Sci. Rep. 2019 9 1 17437 10.1038/s41598‑019‑53505‑7 31767874
    [Google Scholar]
  22. Asiimwe D. Mauti G.O. Kiconco R. Prevalence and risk factors associated with type 2 diabetes in elderly patients aged 45‐80 years at Kanungu District. J. Diabetes Res. 2020 2020 1 1 5 10.1155/2020/5152146
    [Google Scholar]
  23. Kumar K.N. Katkuri S. Ramyacharitha I. A study to assess prevalence of diabetes mellitus and its associated risk factors among adult residents of rural Khammam. IJCMPH 2018 5 4 1360 1365
    [Google Scholar]
  24. Basit A. Fawwad A. Qureshi H. Shera A.S. Prevalence of diabetes, pre-diabetes and associated risk factors: Second National Diabetes Survey of Pakistan (NDSP), 2016–2017. BMJ Open 2018 8 8 e020961 10.1136/bmjopen‑2017‑020961 30082350
    [Google Scholar]
  25. Thakur S.K. Dhakal S.P. Parajuli S. Sah A.K. Nepal S.P. Paudel B.D. Microalbuminuria and its risk factors in type 2 diabetic patients. J. Nepal Health Res. Counc. 2019 17 1 61 65 10.33314/jnhrc.v17i01.1620 31110390
    [Google Scholar]
  26. Tangvarasittichai S. Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus. World J. Diabetes 2015 6 3 456 480 10.4239/wjd.v6.i3.456 25897356
    [Google Scholar]
  27. Griendling K.K. Camargo L.L. Rios F.J. Lopes A.R. Montezano A.C. Touyz R.M. Oxidative stress and hypertension. Circ. Res. 2021 128 7 993 1020 10.1161/CIRCRESAHA.121.318063 33793335
    [Google Scholar]
  28. Cruz G.M. Vera M.I. Cañetas C.T.E. Chan C.Y. Torres N. Tovar A.R. Mota M.C. Gómez T.J.M. Monter P.C. Lugo R. Solis G.A.L. Nava A.A. Chaya leaf decreased triglycerides and improved oxidative stress in subjects with dyslipidemia. Front. Nutr. 2021 8 666243 10.3389/fnut.2021.666243 34368206
    [Google Scholar]
  29. Rajeshwari A. Divija D.A. Somshekhar G.N. Study of serum sialic acid, microalbuminuria, oxidative stress and antioxidant status in diabetic nephropathy. IJBB 2019 15 1 17 25
    [Google Scholar]
  30. Aslan M. Sabuncu T. Kocyigit A. Celik H. Selek S. Relationship between total oxidant status and severity of diabetic nephropathy in type 2 diabetic patients. Nutr. Metab. Cardiovasc. Dis. 2007 17 10 734 740 10.1016/j.numecd.2006.08.005 17321120
    [Google Scholar]
  31. Kharroubi A.T. Darwish H.M. Akkawi M.A. Ashareef A.A. Almasri Z.A. Bader K.A. Khammash U.M. Total antioxidant status in type 2 diabetic patients in palestine. J. Diabetes Res. 2015 2015 1 7 10.1155/2015/461271 26090472
    [Google Scholar]
  32. Najafi A. Pourfarzam M. Zadhoush F. Oxidant/antioxidant status in type-2 diabetes mellitus patients with metabolic syndrome. J. Res. Med. Sci. 2021 26 1 6 10.4103/jrms.JRMS_249_20 34084185
    [Google Scholar]
  33. Lim S. Barter P. Antioxidant effects of statins in the management of cardiometabolic disorders. J. Atheroscler. Thromb. 2014 21 10 997 1010 10.5551/jat.24398 25132378
    [Google Scholar]
  34. German C.A. Liao J.K. Understanding the molecular mechanisms of statin pleiotropic effects. Arch. Toxicol. 2023 97 6 1529 1545 10.1007/s00204‑023‑03492‑6 37084080
    [Google Scholar]
  35. Kurajoh M. Fukumoto S. Yoshida S. Akari S. Murase T. Nakamura T. Ishii H. Yoshida H. Nagata Y. Morioka T. Mori K. Imanishi Y. Hirata K. Emoto M. Uric acid shown to contribute to increased oxidative stress level independent of xanthine oxidoreductase activity in MedCity21 health examination registry. Sci. Rep. 2021 11 1 7378 10.1038/s41598‑021‑86962‑0 33795813
    [Google Scholar]
  36. Indriani V. Lestari T. Dewantari V. Duration of diabetes as an important risk factor of microalbuminuria in type 2 diabetes. Universa Medicina 2020 39 1 42 46 10.18051/UnivMed.2020.v39.42‑46
    [Google Scholar]
  37. Saleem T. Dahpy M. Ezzat G. Abdelrahman G. Aziz A.E. Farghaly R. The profile of plasma free amino acids in type 2 diabetes mellitus with insulin resistance: Association with microalbuminuria and macroalbuminuria. Appl. Biochem. Biotechnol. 2019 188 3 854 867 10.1007/s12010‑019‑02956‑9 30706418
    [Google Scholar]
  38. Ogunmuyiwa O. Hypertension and diabetes comorbidity: Factors that are associated with their joint occurrence. Doctoral dissertation, Thesis Georgia State University 2023
    [Google Scholar]
  39. Nicola P. Ardeleanu E. Gadau C. Dorobantu M. Darabont R. Tilea I. Varga A. Folescu R. Zamfir A.S. Boanca M. Strat L. Baaj T. Gurgus D. Evaluation of biochemical and clinical parametres of hypertension with type 2 diabetes mellitus. Revista de Chimie 2018 69 9 2402 2406 10.37358/RC.18.9.6542
    [Google Scholar]
  40. Khan Z.K. Majeed A. Rashid A. The risk factors associated with diabetic dyslipidemia and anthropometric parameters linked with and without dyslipidemia in type 2 diabetes mellitus. PAFMJ 2020 70 2 628 633
    [Google Scholar]
/content/journals/cdr/10.2174/0115733998336940241219182916
Loading
Trends in Total Antioxidant Status and Other Biochemical Parameters in Type 2 Diabetes Mellitus: A Case-control Study
Bentham Science Publishers ; https://doi.org/10.2174/0115733998336940241219182916
/content/journals/cdr/10.2174/0115733998336940241219182916
/content/journals/cdr/10.2174/0115733998336940241219182916
Loading

Data & Media loading...


  • Article Type:     Research Article
Keywords: antioxidant status ; diabetic complications ; micro-albuminuria ; Type 2 diabetes

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test